Evidence map›Paper›PMID 31052313›Full record

ArticleInternational journal of molecular sciences2019

Active Fraction from Embryo Fish Extracts Induces Reversion of the Malignant Invasive Phenotype in Breast Cancer through Down-regulation of TCTP and Modulation of E-cadherin/β-catenin Pathway.

Sara Proietti, Alessandra Cucina, Andrea Pensotti, Pier Mario Biava, Mirko Minini, Noemi Monti, Angela Catizone, Giulia Ricci, Erica Leonetti, Abdel Halim Harrath and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Synchronization between Attractors: Genomic Mechanism of Cell-Fate Change.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Sara ProiettiDepartment of Surgery "Pietro Valdoni", Sapienza University of Rome, 00161 Rome, Italy. sara.proietti@uniroma1.it.
Alessandra CucinaDepartment of Surgery "Pietro Valdoni", Sapienza University of Rome, 00161 Rome, Italy. alessandra.cucina@uniroma1.it.
Andrea PensottiFAST, University Campus Bio-Medico, 00128 Rome, Italy. andreapensotti@gmail.com.
Pier Mario BiavaScientific Institute of Research and Health Care (IRCCS) Multimedica, 20099 Milano, Italy. piermario.biava@gmail.com.
Mirko MininiDepartment of Surgery "Pietro Valdoni", Sapienza University of Rome, 00161 Rome, Italy. mirko.minini@uniroma1.it.
Noemi MontiDepartment of Surgery "Pietro Valdoni", Sapienza University of Rome, 00161 Rome, Italy. monti_noemi@libero.it.
Angela CatizoneDepartment of Anatomy, Histology, Forensic-Medicine and Orthopedics, "Sapienza" University of Rome, 00161 Rome, Italy. angela.catizone@uniroma1.it.
Giulia RicciDepartment. of Experimental Medicine, Università degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy. giulia.ricci@uniroma1.it.
Erica LeonettiDepartment of Anatomy, Histology, Forensic-Medicine and Orthopedics, "Sapienza" University of Rome, 00161 Rome, Italy. erica.leonetti@uniroma1.it.
Abdel Halim HarrathDepartment of Zoology, College of Science, King Saud University, Riyadh 2455, Saudi Arabia. salwasel@ksu.edu.sa.
Saleh H AlwaselDepartment of Zoology, College of Science, King Saud University, Riyadh 2455, Saudi Arabia. halim.harrath@gmail.com.
Mariano BizzarriDepartment of Anatomy, Histology, Forensic-Medicine and Orthopedics, "Sapienza" University of Rome, 00161 Rome, Italy. mariano.bizzarri@uniroma1.it.
Sapienza University of Rome · ITKing Saud University · SAMultiMedica · ITPoliclinico Umberto I · ITUniversità Campus Bio-Medico · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some yet unidentified factors released by both oocyte and embryonic microenvironments demonstrated to be non-permissive for tumor development and display the remarkable ability to foster cell/tissue reprogramming, thus ultimately reversing the malignant phenotype. In the present study we observed how molecular factors extracted from Zebrafish embryos during specific developmental phases (20 somites) significantly antagonize proliferation of breast cancer cells, while reversing a number of prominent aspects of malignancy. Embryo extracts reduce cell proliferation, enhance apoptosis, and dramatically inhibit both invasiveness and migrating capabilities of cancer cells. Counteracting the invasive phenotype is a relevant issue in controlling tumor spreading and metastasis. Moreover, such effect is not limited to cancerous cells as embryo extracts were also effective in inhibiting migration and invasiveness displayed by normal breast cells undergoing epithelial-mesenchymal transition upon TGF-β1 stimulation. The reversion program involves the modulation of E-cadherin/β-catenin pathway, cytoskeleton remodeling with dramatic reduction in vinculin, as well as downregulation of TCTP and the concomitant increase in p53 levels. Our findings highlight that-contrary to the prevailing current "dogma", which posits that neoplastic cells are irreversibly "committed"-the malignant phenotype can ultimately be "reversed", at least partially, in response to environmental morphogenetic influences.

Indexed as

AnimalsAntineoplastic AgentsApoptosisbeta CateninBiomarkers, TumorBreast NeoplasmsCadherinsCell Line, TumorCell MovementDown-RegulationEmbryo, NonmammalianHumansPhenotypeTissue ExtractsTumor Protein, Translationally-Controlled 1ZebrafishAntineoplastic Agentsbeta CateninBiomarkers, TumorCadherinsTissue ExtractsTPT1 protein, humanTumor Protein, Translationally-Controlled 1cytoskeletonE-cadherin/β-cateninEmbryo fish extractp53TCTPTumor Reversion

Identifiers

PMID31052313
PMCPMC6539734
OpenAlexW2943751717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.